Discover new horizons in Transient Protein Expression
History
The Magellan Biologics and Consulting history starts in 2014, when a Group of renowned experts in protein expression in mammalian cells from ExcellGene, a Contract Development and Manufacturing Organization, decide to offer their expertise to the scientific community involved in discovery and pre-clinical development projects. A new company is thus established in Portugal, headquartered in Torres Novas and given the name of the most famous Portuguese explorer Magellan.
Through their first consulting mandates, between Year 2015 and Year 2019, the founders recognize the need from a fast-growing number of R&D labs worldwide to develop their own capacity to produce in-house large varieties of candidate proteins to feed their screening programs. Based on the knowledge acquired at ExcellGene, on its proprietary processes and cell lines and through an exclusive licensing agreement Magellan Biologics and Consulting starts its laboratory operations in 2019, first with the Institute for Research and Innovation in Health in Porto and then, since 2021 at Biocant, the Portugal Science & Technology Park for Biotech and Life Science in Cantanhede, in the Coimbra region.
As a first fruit of a joint R&D program between ExcellGene and Magellan, CHO 4Tx®, a revolutionary ready-to-use transfection kit for CHO cells is launched in 2022 and commercialized to support the scientific community discovering new horizons in Transient Protein Expression.
Vision
The therapeutic and diagnostic role of recombinant proteins is expanding in a growing number of applications, strongly contributing to medical progress in more and more life-threatening conditions. The discovery stage, which aim is to identify new candidates for further clinical development, is the first key to successful R&D programs and the phase for Magellan’s know-how and products to make a difference. By accelerating basic and applied research we’re willing to contribute to improve and save patients’ lives.
Mission
We make Protein Expression in mammalian cells easy and efficient for the benefit of the international scientific community involved in R&D on candidate proteins either for therapeutic or diagnostic use.
Values
Science
Professional
– Expertise – Scientific mind – Transparency
Service
Proactive & Responsive
– Self-challenging and self-improving – Openness – Helpfulness
Progress
Innovative
& Pragmatic
– Continuous process and product development – Solution-oriented
Fields of Activity
Science
Service
Progress
Creative & Methodical
Proactive
Innovative & Pragmatic
– Expertise – Scientific mindset – Transparency
– Self-challenging and self-improving – Openness – Helpfulness
– Continuous process and product development – Solution-oriented – Result-oriented
Team
Dr. Maria Wurm Founder and Chief Executive Officer
Prof Florian Wurm Founder and Chief Scientific Officer
Jérôme Puginier, MSc Head of Business Development and commercial operations
Advising and training to our clients willing to set up a transient protein expression unit in their own lab (protocols, technique, materials and equipment)
Laboratory Biocant Park -Parque Tecnológico de Cantanhede Edifício III – Laboratório 5 3060-197 Cantanhede, Portugal
+351 911 004 699 +351 231 249 290
Welcome on board!
Subscribe to our Newsletter and stay updated!
Get Updates!
If you opt in above we use this information send related content
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with itOkPrivacy policy